Our study underscores the potential benefits of pharmacist-led post-AKI bundled care strategy in outpatient settings. We observed a significant reduction in the utilization of modifiable nephrotoxic drugs, indicating the effectiveness of pharmacist interventions in optimizing medication regimens to mitigate renal harm.
Keyphrases
- acute kidney injury
- healthcare
- quality improvement
- palliative care
- cardiac surgery
- randomized controlled trial
- systematic review
- physical activity
- affordable care act
- emergency department
- stem cells
- mesenchymal stem cells
- human health
- risk assessment
- drug induced
- cell therapy
- light emitting
- smoking cessation
- electronic health record